- Home
- LIVN vs INDV Comparison
LIVN vs INDV Comparison
Compare LIVN & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIVN
- INDV
- Stock Information
- Founded
- LIVN 1987
- INDV 1994
- Country
- LIVN United Kingdom
- INDV United States
- Employees
- LIVN N/A
- INDV N/A
- Industry
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- INDV Biotechnology: Pharmaceutical Preparations
- Sector
- LIVN Health Care
- INDV Health Care
- Exchange
- LIVN Nasdaq
- INDV Nasdaq
- Market Cap
- LIVN 2.1B
- INDV 1.9B
- IPO Year
- LIVN 1993
- INDV N/A
- Fundamental
- Price
- LIVN $54.53
- INDV $22.97
- Analyst Decision
- LIVN Strong Buy
- INDV Strong Buy
- Analyst Count
- LIVN 7
- INDV 4
- Target Price
- LIVN $59.71
- INDV $23.75
- AVG Volume (30 Days)
- LIVN 583.7K
- INDV 2.0M
- Earning Date
- LIVN 10-29-2025
- INDV 10-23-2025
- Dividend Yield
- LIVN N/A
- INDV N/A
- EPS Growth
- LIVN N/A
- INDV N/A
- EPS
- LIVN N/A
- INDV 0.42
- Revenue
- LIVN $1,309,329,000.00
- INDV $1,173,000,000.00
- Revenue This Year
- LIVN $11.29
- INDV N/A
- Revenue Next Year
- LIVN $6.59
- INDV $3.00
- P/E Ratio
- LIVN N/A
- INDV $55.39
- Revenue Growth
- LIVN 8.23
- INDV 2.27
- 52 Week Low
- LIVN $32.48
- INDV $7.33
- 52 Week High
- LIVN $58.91
- INDV $25.10
- Technical
- Relative Strength Index (RSI)
- LIVN 50.60
- INDV 48.52
- Support Level
- LIVN $56.42
- INDV $22.27
- Resistance Level
- LIVN $57.53
- INDV $25.10
- Average True Range (ATR)
- LIVN 1.35
- INDV 0.64
- MACD
- LIVN -0.70
- INDV -0.45
- Stochastic Oscillator
- LIVN 10.25
- INDV 24.73
About LIVN LivaNova PLC
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
About INDV Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.